Fujirebio

(IN BRIEF) Fujirebio Holdings and Sysmex Corporation have entered into a Basic Agreement on Business Collaboration in the field of immunoassay. This collaboration will involve various aspects such as research and development, production, clinical development, and sales-marketing. Sysmex, known for … Read the full press release →

(IN BRIEF) H.U. Group Holdings Inc. and Fujirebio have announced the launch of Lumipulse G NfL CSF and Lumipulse G NfL Blood assays for the fully automated random-access LUMIPULSE G immunoassay systems. These assays can quantitatively measure Neurofilament light (NfL) … Read the full press release →